Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT01402271What this trial is testingPazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer European Organisation for Research and Treatment of Cancer - EORTC 88
Early research (Phase 1)Looking for participantsNCT04811703What this trial is testingPressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian CancerWho this might be right forMetastatic Ovarian CarcinomaPeritoneal CarcinomatosisStage III Ovarian Cancer+4 more Hospices Civils de Lyon 15
Testing effectiveness (Phase 2)Study completedNCT02107937What this trial is testingPhase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian CarcinomaWho this might be right forOvarian NeoplasmsOvarian Epithelial Cancer SOTIO a.s. 136
Testing effectiveness (Phase 2)UnknownNCT04375956What this trial is testingStudy on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer PatientsWho this might be right forOvarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Early research (Phase 1)Study completedNCT00413075What this trial is testingStudy of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaWho this might be right forSolid TumorLymphoma Valerio Therapeutics 121
Not applicableLooking for participantsNCT02073500What this trial is testingPeritoneal Surface Malignancies - Characterization, Models and Treatment StrategiesWho this might be right forPseudomyxoma PeritoneiColorectal CarcinomaOvarian Carcinoma+1 more Oslo University Hospital 300
Early research (Phase 1)Study completedNCT00045175What this trial is testingUCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer University Health Network, Toronto 33
Testing effectiveness (Phase 2)Study completedNCT00070096What this trial is testingIxabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell TumorsWho this might be right forBrain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+1 more Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Looking for participantsNCT06023862What this trial is testingA Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)Who this might be right forOvarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more Yonsei University 198
Early research (Phase 1)Study completedNCT00004082What this trial is testingCombination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial TumorsWho this might be right forEndometrial CancerFallopian Tube CancerOvarian Cancer+1 more Beth Israel Deaconess Medical Center
Not applicableNot Yet RecruitingNCT07267780What this trial is testingContribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.Who this might be right forOvarian CarcinomaCervical CarcinomaEndometrial Carcinoma+3 more National Cancer Institute, Naples 130
Testing effectiveness (Phase 2)Study completedNCT00193297What this trial is testingTopotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal CarcinomaWho this might be right forOvary Cancer SCRI Development Innovations, LLC 50
Not applicableStudy completedNCT02221076What this trial is testingProbe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.Who this might be right forCervix CancerEndometrium CancerOvarian Cancer+1 more Mauna Kea Technologies 16
Testing effectiveness (Phase 2)Study completedNCT02611024What this trial is testingPharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsWho this might be right forAdvanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more PharmaMar 316
Testing effectiveness (Phase 2)Ended earlyNCT02900560What this trial is testingStudy of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian CancerWho this might be right forEpithelial Ovarian Cancer Translational Research in Oncology 34
Not applicableWithdrawnNCT00460200What this trial is testingDepression and Interleukin-6 Production in Patients With Ovarian Epithelial CancerWho this might be right forDepressionFatigueOvarian Cancer+2 more Jonsson Comprehensive Cancer Center
Very early researchStudy completedNCT01747798What this trial is testingAuranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerWho this might be right forRecurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer Mayo Clinic 10
Testing effectiveness (Phase 2)Looking for participantsNCT04895709What this trial is testingBMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsWho this might be right forCervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more Bristol-Myers Squibb 1,109
Testing effectiveness (Phase 2)Study completedNCT00939809What this trial is testingA6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CarcinomaMalignant Ovarian Mixed Epithelial TumorOvarian Brenner Tumor+7 more Gynecologic Oncology Group 31